Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CANNOTCMKTS:DIGPOTCMKTS:PKPHNASDAQ:XXII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANNTREES$0.02-7.9%$0.03$0.01▼$0.08$2.25M-0.3291,213 shs251,601 shsDIGPHypha Labs$0.03$0.03$0.01▼$0.07$3.44M0.4399,466 shsN/APKPHPeak Pharmaceuticals$1.02-6.7%$2.19$0.52▼$9.12$399K0.549,053 shs100 shsXXII22nd Century Group$7.53-7.4%$18.30$6.28▼$2,837.04$4.12M1.9322,167 shs27,403 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANNTREES-7.88%-33.69%-28.90%-48.06%-70.55%DIGPHypha Labs0.00%0.00%+7.14%+22.45%+65.38%PKPHPeak Pharmaceuticals0.00%-31.71%-0.25%-77.39%-53.75%XXII22nd Century Group-7.38%-7.15%-56.54%-78.32%-99.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANNTREESN/AN/AN/AN/AN/AN/AN/AN/ADIGPHypha LabsN/AN/AN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AXXII22nd Century Group0.8569 of 5 stars0.05.00.00.01.90.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANNTREES 0.00N/AN/AN/ADIGPHypha Labs 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/AXXII22nd Century Group 0.00N/AN/AN/ALatest PKPH, CANN, DIGP, and XXII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/27/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)6/11/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)5/24/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)5/10/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)4/24/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E) ➝ Sell (E+)4/8/2025XXII22nd Century GroupWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E)(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANNTREES$18.14M0.11N/AN/A($0.01) per share-1.87DIGPHypha Labs$2.70M1.27N/AN/A($0.03) per share-1.00PKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AXXII22nd Century Group$24.38M0.16N/AN/A$53.71 per share0.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANNTREES-$7.08M-$0.04N/A∞N/A-37.08%N/A-24.24%N/ADIGPHypha Labs$250KN/A0.00∞N/AN/AN/A-35.56%N/APKPHPeak Pharmaceuticals-$160KN/A0.00∞N/AN/AN/A-159.55%N/AXXII22nd Century Group-$15.16M-$2,986.49N/A∞N/A-57.62%-524.68%-57.04%8/12/2025 (Estimated)Latest PKPH, CANN, DIGP, and XXII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025XXII22nd Century Group-$25.30-$43.47-$18.17-$2.50$4.70 million$5.96 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANNTREESN/AN/AN/AN/AN/ADIGPHypha LabsN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AXXII22nd Century GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCANNTREESN/A0.160.08DIGPHypha LabsN/A0.910.91PKPHPeak PharmaceuticalsN/A0.150.15XXII22nd Century GroupN/A0.680.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANNTREES11.28%DIGPHypha LabsN/APKPHPeak PharmaceuticalsN/AXXII22nd Century Group18.06%Insider OwnershipCompanyInsider OwnershipCANNTREES45.00%DIGPHypha Labs10.80%PKPHPeak Pharmaceuticals18.40%XXII22nd Century Group0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANNTREES80110.93 million61.01 millionNot OptionableDIGPHypha Labs20114.71 million102.32 millionNot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionableXXII22nd Century Group80510,000506,000OptionablePKPH, CANN, DIGP, and XXII HeadlinesRecent News About These Companies22nd Century Group's (XXII) Sell (E+) Rating Reaffirmed at Weiss RatingsJune 28 at 2:28 AM | americanbankingnews.comXXII - 22nd Century Group Inc Price vs Fair Value - MorningstarJune 26, 2025 | morningstar.comM22nd Century Group developing 100mm very low nicotine cigaretteJune 26, 2025 | msn.com22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine ConsumptionJune 26, 2025 | globenewswire.com22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store ChainJune 24, 2025 | finance.yahoo.com22nd Century announces updates to Pinnacle manufacturing, marketing agreementJune 24, 2025 | msn.com22nd Century limits fiscal 2024 executive compensation, proposes another reverse stock splitMay 27, 2025 | journalnow.comJEmerging Growth Research Releases Q1 2025 Update Report on 22nd Century GroupMay 21, 2025 | newsfilecorp.comN22nd Century to Present at the Emerging Growth Conference on May 21, 2025May 19, 2025 | globenewswire.com22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call TranscriptMay 14, 2025 | msn.com22nd Century: Q1 Earnings SnapshotMay 14, 2025 | wtop.comW22nd Century reports lower quarterly loss, still no net revenue from very-low-nicotine cigarettesMay 14, 2025 | journalnow.comJ22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...May 14, 2025 | finance.yahoo.com22nd Century Group, Inc. (XXII) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.com22nd Century Group Reports First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.com22nd Century Group, Inc.: 22nd Century Group Completes Sale of Needle Rock Farms AssetsMay 9, 2025 | finanznachrichten.de22nd Century Group, Inc. Reports $1 Million Debt Repayment, Achieving $3.8 Million Year-to-Date ReductionMay 9, 2025 | nasdaq.com22nd Century Group, Inc. Enhances Balance Sheet with $770,000 Asset Sale ProceedsMay 8, 2025 | quiverquant.comQ22nd Century Group Completes Sale of Needle Rock Farms AssetsMay 8, 2025 | globenewswire.com22nd Century Group, Inc.: 22nd Century Group Further Reduces Debt by $1.0 Million Following Financing TransactionMay 8, 2025 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimePKPH, CANN, DIGP, and XXII Company DescriptionsTREES OTCMKTS:CANN$0.02 0.00 (-7.88%) As of 06/30/2025 03:47 PM EasternTrees Corporation provides products and services to the regulated cannabis industry in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and retail dispensary store in Englewood, Colorado, as well as retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Lakewood, Colorado.Hypha Labs OTCMKTS:DIGP$0.03 0.00 (0.00%) As of 06/27/2025Hypha Labs, Inc., cultivates, produces, and sells psychedelic and functional mushroom in the United States. It has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.Peak Pharmaceuticals OTCMKTS:PKPH$1.02 -0.07 (-6.65%) As of 06/27/2025Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.22nd Century Group NASDAQ:XXII$7.53 -0.60 (-7.38%) As of 06/30/2025 04:00 PM Eastern22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
